Cyclopharm Presentation - FNN Investor Event - Sep 2018

 

Cyclopharm Managing Director & CEO, James McBrayer presents an update on its radiopharmaceutical products used in imaging, sales of Technegas and its US FDA application.

Key points:

– Cyclopharm Limited is a leading diagnostic lung imaging company
– Profitable & Growing MedTech
– USA FDA approval set to increase growth
– First in class technology in the 56 countries
– 4M Technegas patient scans
– Opportunity to broaden Technegas applications beyond pulmonary embolism diagnosis

For more information, watch Managing Director & CEO James McBrayer present.

Privacy Preference Center

Cookies

We use cookies to better understand your use of this website.

Google Analytics, IRM Investor Centre

Close your account?

Your account will be closed and all data will be permanently deleted and cannot be recovered. Are you sure?